ArticleBMJ open2019
Neonatal azithromycin administration to prevent infant mortality: study protocol for a randomised controlled trial.
Article in BMJ open, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03682653 (Neonates and Azithromycin, an Innovation in the Treatment of Children in Burkina Faso), which is not on this map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neonates and Azithromycin, an Innovation in the Treatment of Children in Burkina Faso
Who cites it
13 citing papers in PubMed, 18 citations in OpenAlex.
- Azithromycin for infants at risk of poor growth and development: A pooled secondary analysis of two randomized controlled trials.PloS one · 2025Trial
- Neonatal Azithromycin Exposure and Childhood Growth: Long-Term Follow-Up of a Randomized Controlled Trial.The American journal of tropical medicine and hygiene · 2024Trial
- Neonatal anthropometric indicators of infant growth and mortality in Burkina Faso.Public health nutrition · 2024Trial
- Neonatal Azithromycin Administration and Growth during Infancy: A Randomized Controlled Trial.The American journal of tropical medicine and hygiene · 2023Trial
- Influence of maternal age on birth and infant outcomes at 6 months: a cohort study with quantitative bias analysis.International journal of epidemiology · 2023Trial
- Effect of Neonatal Azithromycin on All-Cause and Cause-Specific Infant Mortality: A Randomized Controlled Trial.The American journal of tropical medicine and hygiene · 2022Trial
- Trial
- Associations between Antenatal Care Visit Attendance and Infant Mortality and Growth.The American journal of tropical medicine and hygiene · 2024Article
- Anthropometric Differences in Community- Versus Clinic-Recruited Infants Participating in a Trial of Azithromycin for Prevention of Childhood Mortality in Burkina Faso.The American journal of tropical medicine and hygiene · 2023Article
- Infant mortality and growth failure after oral azithromycin among low birthweight and underweight neonates: A subgroup analysis of a randomized controlled trial.PLOS global public health · 2023Article
- Neonatal azithromycin administration for prevention of infant mortality.NEJM evidence · 2022Article
- Antenatal care attendance and risk of low birthweight in Burkina Faso: a cross-sectional study.BMC pregnancy and childbirth · 2021Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors at 2 institutions in 2 countries.
Funding
Abstract
introductionBiannual mass azithromycin distribution to children aged 1-59 months has been shown to reduce all-cause mortality. Children under 28 days of age were not treated in studies evaluating mass azithromycin distribution for child mortality due to concerns related to infantile hypertrophic pyloric stenosis (IHPS). Here, we report the design of a randomised controlled trial to evaluate the efficacy and safety of administration of a single dose of oral azithromycin during the neonatal period. METHODS AND ANALYSIS: The ETHICS AND DISSEMINATION: This study was approved by the Institutional Review Boards at the University of California, San Francisco in San Francisco, USA (Protocol #18-25027) and the Comité National d'Ethique pour la Recherche in Ouagadougou, Burkina Faso (Protocol #2018-10-123). The findings of this trial will be presented at local, regional and international meetings and published in open access peer-reviewed journals. TRIAL REGISTRATION NUMBER: NCT03682653; Pre-results.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.